Mylan Faces Patent Suits Over Generic Estradiol

By Jesse Greenspan · February 24, 2011, 7:19 PM EST

Units of Novartis AG and Hisamitsu Pharmaceutical Co. Inc. accused Mylan Inc. of infringing two of their patents by seeking to market a generic estradiol transdermal system in a pair of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al

Case Number

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 22, 2011

Recent Articles By Jesse

May 12, 2011
Executive Risk Must Cover Hospital Privacy Row: Judge
May 09, 2011
DOD Services Contracts Outpace Other Growth
April 28, 2011
Merck To Abide By Discharge Diet To End Enviro Suit
April 27, 2011
FOIA Request Filed As Avastin Safety Hearing Nears
April 15, 2011
Cypress Sued Over Unapproved Cold Medication
April 14, 2011
FDA Recalls Radiation Shield That Sheds Tungsten
April 01, 2011
BSC Poached Worker Suit To Move Forward In Calif.
March 17, 2011
Mont. Orders AG To Join Health Care Reform Challenge
March 15, 2011
Gilead, Roche Sue To Block Generic Tamiflu
March 14, 2011
Pa. Action Over Dead Health Care Plan Targets Pols